Inhaled Cromolyn Sodium: Its Place in Asthma Management
There has been a renewal of interest in inhaled drugs for the treatment of bronchial asthma in this country. Cromolyn sodium has been used as a first fine prophylactic agent in children with mild to moderate asthma with considerable success in our practice for the past several years. This report reviews previous clinical studies comparing cromolyn and theophylline, as well as a point by point pharmacologic comparison of these two agents. Reasons for previous treatment failures, and clinical guidelines to achieve maximum benefit with cromolyn are discussed.
Document Type: Research Article
Affiliations: University of Connecticut Medical School; Department of Pediatrics, Hartford Hospital, Hartford, CT
Publication date: 01 December 1984
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma and by having the potential to directly impact the quality of patient care. AAP welcomes the submission of original works including peer-reviewed original research and clinical trial results. Additionally, as the official journal of the Eastern Allergy Conference (EAC), AAP will publish content from EAC poster sessions as well as review articles derived from EAC lectures.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service. - Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Commercial level: Permission to use content
- www.JFoodAllergy.com
- Ingenta Connect is not responsible for the content or availability of external websites
Receive new issue alert- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content